Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Powers

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Scientific Reports|April 18, 2019
Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cellsTessa Knox, Eva Sahakian, Debarati Banik, et al.
Cancer Immunology, Immunotherapy : CII|December 5, 2022
Anti-4-1BB immunotherapy enhances systemic immune effects of radiotherapy to induce B and T cell-dependent anti-tumor immune activation and improve tumor control at unirradiated sitesAlexandra L Martin, Chase Powell, Mate Z Nagy, et al.
Neurobiology of Aging|December 31, 2013
Genetic and neuroanatomic associations in sporadic frontotemporal lobar degenerationCorey T McMillan, Jon B Toledo, Brian B Avants, et al.
Research Square|July 10, 2026
Clade-3 Bat Sarbecovirus PRD0038 Reveals Constraints on Coronavirus Emergence and Immune SensitivityAnfal Abdelgadir, Edgar Kong, Ruth Parsons, et al.
Blood Advances|February 12, 2025
Mitigating T-cell mitochondrial dysfunction in CLL to augment CAR T-cell therapy: evaluation in an immunocompetent modelWael Gamal, Nienke B Goedhart, Helga Simon-Molas, et al.
Blood|May 28, 2017
T cells lacking HDAC11 have increased effector functions and mediate enhanced alloreactivity in a murine modelDavid M Woods, Karrune V Woan, Fengdong Cheng, et al.
Oncogene|June 2, 2025
An FGFR-p53 developmental signaling axis drives salivary cancer progressionAdele M Musicant, Julia M R Billington, Jeffrey S Damrauer, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 3, 2012
Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosisDavid J Irwin, Corey T McMillan, Johannes Brettschneider, et al.
Nature Microbiology|September 25, 2023
Host range, transmissibility and antigenicity of a pangolin coronavirusYixuan J Hou, Shiho Chiba, Sarah R Leist, et al.
Research Square|November 14, 2023
Adjuvant-dependent effects on the safety and efficacy of inactivated SARS-CoV-2 vaccines during heterologous infection by a SARS-related coronavirusMark Heise, Jacob Dillard, Sharon Taft-Benz, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Scientific Reports|April 18, 2019
Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cellsTessa Knox, Eva Sahakian, Debarati Banik, et al.
Cancer Immunology, Immunotherapy : CII|December 5, 2022
Anti-4-1BB immunotherapy enhances systemic immune effects of radiotherapy to induce B and T cell-dependent anti-tumor immune activation and improve tumor control at unirradiated sitesAlexandra L Martin, Chase Powell, Mate Z Nagy, et al.
Neurobiology of Aging|December 31, 2013
Genetic and neuroanatomic associations in sporadic frontotemporal lobar degenerationCorey T McMillan, Jon B Toledo, Brian B Avants, et al.
Research Square|July 10, 2026
Clade-3 Bat Sarbecovirus PRD0038 Reveals Constraints on Coronavirus Emergence and Immune SensitivityAnfal Abdelgadir, Edgar Kong, Ruth Parsons, et al.
Blood Advances|February 12, 2025
Mitigating T-cell mitochondrial dysfunction in CLL to augment CAR T-cell therapy: evaluation in an immunocompetent modelWael Gamal, Nienke B Goedhart, Helga Simon-Molas, et al.
Blood|May 28, 2017
T cells lacking HDAC11 have increased effector functions and mediate enhanced alloreactivity in a murine modelDavid M Woods, Karrune V Woan, Fengdong Cheng, et al.
Oncogene|June 2, 2025
An FGFR-p53 developmental signaling axis drives salivary cancer progressionAdele M Musicant, Julia M R Billington, Jeffrey S Damrauer, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 3, 2012
Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosisDavid J Irwin, Corey T McMillan, Johannes Brettschneider, et al.
Nature Microbiology|September 25, 2023
Host range, transmissibility and antigenicity of a pangolin coronavirusYixuan J Hou, Shiho Chiba, Sarah R Leist, et al.
Research Square|November 14, 2023
Adjuvant-dependent effects on the safety and efficacy of inactivated SARS-CoV-2 vaccines during heterologous infection by a SARS-related coronavirusMark Heise, Jacob Dillard, Sharon Taft-Benz, et al.
Pageof 6